Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome
- 20 December 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (19) , L20-L25
- https://doi.org/10.1016/0002-9149(88)90011-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentryAmerican Heart Journal, 1987
- Encainide for treatment of supraventricular tachycardias associated with the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1986
- Effect of encainide and flecainide on chronic ectopic atrial tachycardiaJournal of the American College of Cardiology, 1986
- Suppression of incessant supraventricular tachycardia by intravenous and oral encainideJournal of the American College of Cardiology, 1984
- Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmiasThe American Journal of Cardiology, 1984
- Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathwayThe American Journal of Cardiology, 1984
- Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.Circulation, 1984
- Electrophysiology of oral encainideThe American Journal of Cardiology, 1982
- Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.Circulation, 1981